Retinal Diseases and Treatments

Review finds no consistent link between GLP-1 drugs and wet age-related macular degeneration

This review examined human clinical evidence about GLP-1 receptor agonists and neovascular age-related macular degeneration, sometimes called wet age-related macular degeneration, in people with type 2 diabetes. The reviewed studies had conflicting results: one reported higher risk, another lower risk, and two large comparisons found no significant increase. The evidence is observational and does not show that these medicines cause or prevent the eye condition.